{"id":1274,"date":"2016-05-11T16:51:07","date_gmt":"2016-05-11T20:51:07","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=1274"},"modified":"2016-05-11T16:51:07","modified_gmt":"2016-05-11T20:51:07","slug":"secondaries-announced-5-11-2016","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-5-11-2016\/","title":{"rendered":"Secondaries announced 5.11.2016"},"content":{"rendered":"<p>IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. <\/p>\n<p>Company: \tLoxo Oncology, Inc.<br \/>\nSymbol: \tLOXO<br \/>\nPrice: \t\tLast trade $22.44<br \/>\nDescription: \tRe-offer range $21.50-$22.00<br \/>\nTrade Date: \t5\/12<br \/>\nShares: \t1.3 million<br \/>\nUnderwriter(s) \tCiti, Cowen &#038; Co., Stifel<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: \tSpire Inc.<br \/>\nSymbol: \tSR<br \/>\nPrice: \t\tLast trade $64.69<br \/>\nTrade Date: \t5\/12<br \/>\nShares: \t1.85 million<br \/>\nUnderwriter(s) \tMorgan Stanley<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: \tCore Laboratories NV<br \/>\nSymbol: \tCLB<br \/>\nPrice: \t\tLast trade $122.74<br \/>\nDescription: \tRe-offer range $118.45-$120.90<br \/>\nTrade Date: \t5\/12<br \/>\nShares: \t1.3 million<br \/>\nUnderwriter(s) \tCredit Suisse<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: \tCyrusOne Inc.<br \/>\nSymbol: \tCONE<br \/>\nPrice: \t\tLast trade $48.48<br \/>\nDescription: \tRe-offer range $47.00-$48.00<br \/>\nTrade Date: \t5\/12<br \/>\nShares: \t3.1 million<br \/>\nUnderwriter(s) \tCiti, Morgan Stanley<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. Company: Loxo Oncology, Inc. Symbol: LOXO Price: Last trade $22.44 Description: Re-offer range $21.50-$22.00 Trade Date: 5\/12 Shares: 1.3 million Underwriter(s) Citi,[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[814,271,690,813],"class_list":["post-1274","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-clb","tag-cone","tag-loxo","tag-sr"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1274","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=1274"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1274\/revisions"}],"predecessor-version":[{"id":1275,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1274\/revisions\/1275"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=1274"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=1274"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=1274"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}